Almirall
Vitiligo

Vitiligo treatments

Vitiligo is a chronic skin condition that occurs when melanocytes, the cells that produce pigment, suffer an autoimmune attack. 

This leads to a loss of melanocytes which in turn causes the appearance of pale or white patches on the skin. 

Currently, there is no definitive cure, but there are treatments for vitiligo that aim to slow or stop the spread of depigmentation and make patches less noticeable. Some treatments for vitiligo can also encourage pigment to return. The focus is usually on improving appearance, managing progression, and supporting emotional wellbeing. 

What are the main treatments for vitiligo?

There are various treatments for vitiligo that may be suggested. The best approach is usually tailored according to age, skin type, the location and extent of patches, how fast the condition is progressing, and personal preference. 

Topical medications

Topical treatments often serve as the first option. They involve creams or ointments applied directly to affected skin.

  • Corticosteroid creams can help bring pigment back, especially when used early and on smaller areas. Long-term use can thin the skin or cause stretch marks and visible blood vessels, so dermatologists frequently monitor treatment closely.
  • Topical calcineurin inhibitors such as tacrolimus or pimecrolimus work well on sensitive areas like the face and neck. They offer an alternative to steroids when long-term use poses concerns.
  • Vitamin D analogues such as calcipotriene can support repigmentation, typically as part of combination therapy.

Response varies from person to person. Some patches improve well, while others show limited change. 

Oral medications

Doctors tend to consider oral treatment when vitiligo spreads quickly or affects large areas.

Short courses of oral corticosteroids may help halt new patches. Newer options, including Janus kinase (JAK) inhibitors, show promise in slowing progression and supporting repigmentation. For example, topical ruxolitinib, has gained approval in some countries for people aged 12 and older with the non-segmental type of vitiligo. 

Systemic treatments always require careful discussion. 

Light therapy

Phototherapy remains a cornerstone of vitiligo management. Some options include:

  • Narrow-band ultraviolet B (NB-UVB) encourages melanocyte activity and repigmentation.
  • PUVA therapy combines a light-sensitising medicine (psoralen) with UVA exposure. It is used less commonly nowadays because it is more traumatic for patients and safety is a greater concern.
  • Combination approaches that pair phototherapy with topical medicines, such as steroids or calcineurin inhibitors, often improve outcomes.

Many people need treatment two or three times a week for several months. Patches on the face and neck usually respond better than those on hands and feet. Because depigmented skin burns more easily, strict sun protection remains essential throughout treatment. 

Depigmentation

When vitiligo affects most of the body and repigmentation seems unlikely or unwanted, some people choose to depigment the remaining darker skin to achieve a uniform appearance. This option is permanent and requires specialist oversight.

Anyone considering depigmentation needs detailed counselling. The process cannot be reversed, and lifelong sun protection becomes vital because fully depigmented skin burns very easily, which can lead to other more dangerous skin conditions such as actinic keratosis and skin cancer. 

What happens if you don’t treat vitiligo?

Vitiligo does not threaten physical health and many people choose not to treat it. Even so, it is important to understand the implications:

  • Patches often remain or expand. Some may stabilize without medical input, but many continue to change.
  • Depigmented skin offers less natural protection from the sun, so the risk of sunburn and long-term UV damage increases.
  • Visible skin changes can affect confidence and emotional wellbeing. Some people experience distress, anxiety, or social withdrawal.
  • Untreated patches may prompt the use of cosmetic camouflage or cover-up products if appearance becomes a concern.

Non-treatment remains a reasonable choice for stable or limited vitiligo, but a discussion with a dermatologist can help assess risks, explore suitable treatments, and identify supportive options. 

FAQs

References